Published By : 27 Oct 2017 | Published By : QYRESEARCH
Following President Trump’s declaration that the opioid overuse problem becoming increasingly prevalent in the U.S. constitutes a national public health emergency, Walgreens has announced it will stock Narcan, an FDA-approved form of naloxone, across its more than 8,000 pharmacies in the U.S. Narcan can reverse the effects of an opioid overdose, though it doesn’t constitute an alternative to medical treatment. The drug store intends to fully support the national plan to combat drug abuse by utilizing its network to increase the availability of crucial formulations that will help emergency responders deal with the situation better.
On timely administration, Narcan can prove life-saving for victims of opioid overdose, including heroin as well as legal prescription painkillers. Narcan is usually carried by emergency responders in a number of communities and the number of communities mandating carrying Narcan is likely to grow in the coming months due to the strong stance taken by President Trump on the opioid overdose issue. Walgreens plans to initiate Narcan in its pharmacies in all the 45 states of the U.S. in which Narcan is legal, while trying to legalize the formulation in the remaining five. The opioid epidemic has reached alarming proportions in the U.S. in recent years, with the epidemic claimed to be responsible for 91 deaths on average per day in the U.S. Walgreens plans to educate customers on how to use Narcan, since many laypeople remain ignorant about how to administer it.